Literature DB >> 9236952

Assessing patterns of agitation in Alzheimer's disease patients with the Cohen-Mansfield Agitation Inventory. The Alzheimer's Disease Cooperative Study.

E Koss1, M Weiner, C Ernesto, J Cohen-Mansfield, S H Ferris, M Grundman, K Schafer, M Sano, L J Thal, R Thomas, P J Whitehouse.   

Abstract

As part of the effort of the NIA Alzheimer's disease cooperative study to develop improved instruments for quantifying effects in Alzheimer's disease (AD) clinical trials, patterns of agitated behaviors were evaluated with the Cohen-Mansfield Agitation Inventory (CMAI) in 241 AD patients and 64 healthy elderly controls with valid baseline assessment on the CMAI. The test-retest reliability of the CMAI over 1 month was good (r = 0.74 to 0.92). Physically and verbally nonaggressive behaviors were most often reported, whereas physically aggressive behaviors were rare. Frequency of agitated behaviors increased with dementia severity, especially for patients with a Mini-Mental Status Exam score of 0-4. Agitation tended to increase in the evening with dementia severity for the more impaired patients. Amount of agitation did increase after 12 months in all but controls and mildly demented patients. The CMAI shows promise for evaluating a unique aspect of behavior and may be useful in assessing the effects of cognitive enhancers and other types of psychotropic drugs on behavior in dementia patients.

Entities:  

Mesh:

Year:  1997        PMID: 9236952     DOI: 10.1097/00002093-199700112-00007

Source DB:  PubMed          Journal:  Alzheimer Dis Assoc Disord        ISSN: 0893-0341            Impact factor:   2.703


  21 in total

1.  The Revised Memory and Behavior Problems Checklist--Nursing Home: instrument development and measurement of burden among certified nursing assistants.

Authors:  Rebecca S Allen; Louis D Burgio; David L Roth; Rachael Ragsdale; John Gerstle; Michelle S Bourgeois; Katinka Dijkstra; Linda Teri
Journal:  Psychol Aging       Date:  2003-12

2.  Instruments to measure behavioural and psychological symptoms of dementia.

Authors:  Rianne M van der Linde; Blossom C M Stephan; Tom Dening; Carol Brayne
Journal:  Int J Methods Psychiatr Res       Date:  2014-02-05       Impact factor: 4.035

3.  Frequency of behavioral symptoms characterizes agitation in Alzheimer's disease.

Authors:  R E Tractenberg; A Gamst; M F Weiner; E Koss; R G Thomas; L Teri; L Thal
Journal:  Int J Geriatr Psychiatry       Date:  2001-09       Impact factor: 3.485

4.  Regression to the mean: implications for clinical trials of psychotropic agents in dementia.

Authors:  Jeffrey L Cummings; Rochelle E Tractenberg; Anthony Gamst; Linda Teri; Donna Masterman; Leon J Thal
Journal:  Curr Alzheimer Res       Date:  2004-11       Impact factor: 3.498

Review 5.  A risk-benefit assessment of risperidone for the treatment of behavioural and psychological symptoms in dementia.

Authors:  M Zaudig
Journal:  Drug Saf       Date:  2000-09       Impact factor: 5.606

6.  Spanish instrument protocol: new treatment efficacy instruments for Spanish-speaking patients in Alzheimer disease clinical trials.

Authors:  Mary Sano; Susan Egelko; Shelia Jin; Jeffrey Cummings; Christopher M Clark; Sonia Pawluczyk; Ronald J Thomas; Mario Schittini; Leon J Thal
Journal:  Alzheimer Dis Assoc Disord       Date:  2006 Oct-Dec       Impact factor: 2.703

7.  Qualifying change: a method for defining clinically meaningful outcomes of change score computation.

Authors:  R E Tractenberg; S Jin; M Patterson; L S Schneider; A Gamst; R G Thomas; L J Thal
Journal:  J Am Geriatr Soc       Date:  2000-11       Impact factor: 5.562

Review 8.  Atypical antipsychotic drugs in the treatment of behavioural and psychological symptoms of dementia: systematic review.

Authors:  Philip E Lee; Sudeep S Gill; Morris Freedman; Susan E Bronskill; Michael P Hillmer; Paula A Rochon
Journal:  BMJ       Date:  2004-06-11

9.  Zotepine for behavioural and psychological symptoms in dementia: an open-label study.

Authors:  Michael K Rainer; Hermann A M Mucke; Christine Krüger-Rainer; Manfred Haushofer; Sigfried Kasper
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

10.  Pharmacological treatments for alleviating agitation in dementia: a systematic review and network meta-analysis.

Authors:  Khachen Kongpakwattana; Ratree Sawangjit; Itthipol Tawankanjanachot; J Simon Bell; Sarah N Hilmer; Nathorn Chaiyakunapruk
Journal:  Br J Clin Pharmacol       Date:  2018-05-14       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.